Patients with optic neuromyelitis optica who are in stable condition generally do not require lifelong medication, but the specifics depend on the severity of the patient’s condition.
Patients with optic neuromyelitis optica can use hormonal drugs to inhibit the immune response, such as prednisolone, etc., to reduce inflammation and eliminate symptoms, and to relieve the patient’s discomfort. After the patient’s condition has stabilized, the amount of hormone medication used can usually be slowly reduced to avoid the recurrence of the disease caused by sudden stopping of the medication. If the condition is always in a stable state, the patient can stop using the medication without the need for lifelong medication.
If the condition remains stable, the patient can stop taking the medication and does not need to take it for life. However, if the condition is serious, the patient may need to take the medication for life to maintain the stability of the condition, and the specific medication regimen should be determined under the guidance of the doctor.
Optic neuromyelitis is usually caused by an autoimmune reaction, in which the inflammation spreads to the optic nerve and spinal cord tissues, thus causing patients to suffer from vision loss, somatic movement disorders, somatosensory disorders and other manifestations, which affects the quality of life of patients. In severe cases, patients may even suffer from respiratory failure, which may be life-threatening.
It is recommended that patients with optic neuromyelitis optica should seek prompt medical attention to evaluate their condition and follow the doctor’s instructions for treatment.